MAMU
GMED icon

Marathon Asset Management (UK)’s Globus Medical GMED Stock Holding History

Marathon Asset Management (UK)’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,360,788
Closed -$104M – 101
2021
Q3 		$104M Buy
1,360,788
+572,039
+73% +$45.9M 1.27% 30
2021
Q2 		$61.2M Buy
788,749
+122,392
+18% +$8.7M 0.74% 53
2021
Q1 		$41.1M Sell
666,357
-103,151
-13% -$6.53M 0.57% 69
2020
Q4 		$50.2M Sell
769,508
-29,150
-4% -$1.68M 0.71% 56
2020
Q3 		$39.5M Sell
798,658
-97,813
-11% -$5.05M 0.62% 63
2020
Q2 		$42.8M Buy
896,471
+255,273
+40% +$12.3M 0.66% 59
2020
Q1 		$27.3M Sell
641,198
-30,319
-5% -$1.5M 0.49% 72
2019
Q4 		$39.5M Sell
671,517
-51,850
-7% -$2.81M 0.52% 70
2019
Q3 		$37M Sell
723,367
-44,065
-6% -$2.1M 0.49% 74
2019
Q2 		$32.5M Buy
767,432
+13,926
+2% +$605K 0.42% 78
2019
Q1 		$37.2M Buy
753,506
+59,846
+9% +$2.71M 0.5% 72
2018
Q4 		$30M Buy
693,660
+43,299
+7% +$2.16M 0.44% 72
2018
Q3 		$36.9M Sell
650,361
-13,756
-2% -$724K 0.47% 74
2018
Q2 		$33.5M Buy
664,117
+1,534
+0.2% +$80K 0.5% 73
2018
Q1 		$33M Sell
662,583
-109,243
-14% -$5.13M 0.51% 72
2017
Q4 		$31.7M Buy
771,826
+12,126
+2% +$425K 0.49% 72
2017
Q3 		$22.6M Sell
759,700
-14,000
-2% -$427K 0.37% 83
2017
Q2 		$25.6M Buy
773,700
+506,241
+189% +$15.9M 0.44% 75
2017
Q1 		$7.92M Buy
267,459
+8,969
+3% +$245K 0.17% 87
2016
Q4 		$6.41M Sell
258,490
-2,123
-0.8% -$48.2K 0.14% 94
2016
Q3 		$5.88M Buy
+260,613
New +$6.13M 0.13% 94

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Marathon Asset Management (UK)'s GMED Position: Q4 2021 in Review

Marathon Asset Management (UK) sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 1,360,788 shares — an estimated $104M sold.

Marathon Asset Management (UK) first reported a position in GMED in Q3 2016 and held it in 21 quarters. The position peaked at $104M in Q3 2021. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

  • Marathon Asset Management (UK) reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
  • Marathon Asset Management (UK) sold 1,360,788 Globus Medical shares in Q4 2021, an estimated $104M.
  • Marathon Asset Management (UK) first reported a position in Globus Medical in Q3 2016 and held it in 21 quarters.
  • Marathon Asset Management (UK)'s Globus Medical position peaked at $104M in Q3 2021.
  • 373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on Marathon Asset Management (UK)'s 13F filing for Q4 2021, filed 28 Jan 2022.